does ohio medicaid cover glp 1 weight loss medication? It should Ohio to end GLP-1 drug

This is promising data that supports the need for further studies evaluating whether GLP-1 receptor antagonists can reduce risk in this population at high risk for developing cancer. 1 What are next steps for GLP-1 research in this population

2001;30(5):426427 Michele Abate, Vincenzo Salini, CosimaSchiavone& Isabel Andia (2017) Clinical benefits and drawbacks of local corticosteroids injections in tendinopathies, Expert Opinion on Drug Safety, 16:3, 341-349, DOI: 10.1080/14740338.2017.1276561 Kong A, Van der Vliet A, Zadow S

People taking the weight-loss drugs also experienced decreased risks of suicidal ideation, self-harm, bulimia and psychotic disorders such as schizophrenia

A third of Wegovy clinical trial participants lost at least 20% of their body weight